Panagora Asset Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,802
| Closed | -$272K | – | 1554 |
|
|
2022
Q3 | $272K | Buy |
+1,802
| New | +$272K | ﹤0.01% | 1304 |
|
|
2021
Q4 | – | Sell |
-2,601
| Closed | -$361K | – | 1799 |
|
|
2021
Q3 | $361K | Sell |
2,601
-41
| -2% | -$5.69K | ﹤0.01% | 1450 |
|
|
2021
Q2 | $256K | Buy |
2,642
+505
| +24% | +$48.9K | ﹤0.01% | 1581 |
|
|
2021
Q1 | $146K | Sell |
2,137
-78,470
| -97% | -$5.36M | ﹤0.01% | 1805 |
|
|
2020
Q4 | $6.91M | Sell |
80,607
-1,200
| -1% | -$103K | 0.04% | 362 |
|
|
2020
Q3 | $5.32M | Sell |
81,807
-22,501
| -22% | -$1.46M | 0.03% | 384 |
|
|
2020
Q2 | $7.63M | Buy |
104,308
+2,568
| +3% | +$188K | 0.05% | 302 |
|
|
2020
Q1 | $3.46M | Sell |
101,740
-208,699
| -67% | -$7.1M | 0.02% | 444 |
|
|
2019
Q4 | $16.9M | Buy |
310,439
+49,908
| +19% | +$2.72M | 0.08% | 253 |
|
|
2019
Q3 | $10.9M | Buy |
260,531
+26,045
| +11% | +$1.09M | 0.05% | 312 |
|
|
2019
Q2 | $10.3M | Buy |
+234,486
| New | +$10.3M | 0.05% | 334 |
|
|
2018
Q4 | – | Sell |
-26,880
| Closed | -$1.01M | – | 2659 |
|
|
2018
Q3 | $1.01M | Buy |
+26,880
| New | +$1.01M | ﹤0.01% | 1125 |
|
|
2018
Q1 | – | Sell |
-24,548
| Closed | -$662K | – | 2489 |
|
|
2017
Q4 | $662K | Hold |
24,548
| – | – | ﹤0.01% | 1284 |
|
|
2017
Q3 | $918K | Buy |
24,548
+8,248
| +51% | +$308K | ﹤0.01% | 1151 |
|
|
2017
Q2 | $408K | Buy |
+16,300
| New | +$408K | ﹤0.01% | 1414 |
|